share_log

康龙化成(300759.SZ)主要股东信中康成的一致行动人完成减持1600万股

Pharmaron (300759.SZ) major shareholder Xinzhi Kangkang's concerted action has completed a shareholding reduction of 16 million shares.

Zhitong Finance ·  Dec 9 19:51

Pharmaron (300759.SZ) announced that the company's shareholders holding more than 5% of the shares, Shenzhen Xinchungangcheng Investment Partnership...

According to the Zhitong Finance APP, Pharmaron (300759.SZ) announced that one of its shareholders holding more than 5%, Shenzhen Xinchungangcheng Investment Partnership (Limited Partnership) (referred to as "Xinchungangcheng"), and its concerted action partner, Shenzhen Xinchunglongcheng Investment Partnership (Limited Partnership) (referred to as "Xinchunglongcheng"), have cumulatively reduced their shareholding by 16 million shares, accounting for 0.90% of the total share capital. This shareholding reduction plan has been completed.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment